HAROLD E. SELICK - 10 Apr 2023 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Director
Signature
/s/ Asif Ali, Attorney-in-Fact for Harold E. Selick
Issuer symbol
PTGX
Transactions as of
10 Apr 2023
Net transactions value
+$5,391
Form type
4
Filing time
11 Apr 2023, 19:18:54 UTC
Previous filing
18 Jan 2023
Next filing
31 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Options Exercise $5,391 +6,196 +40% $0.8700* 21,506 10 Apr 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Options Exercise $0 -6,196 -100% $0.000000* 0 10 Apr 2023 Common Stock 6,196 $0.8700 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date.
F2 The stock option is vested in full.